{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:31:45Z","timestamp":1793302305626,"version":"4.5.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy And Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI130059"],"award-info":[{"award-number":["R01AI130059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Determining how chemotherapeutic drugs alter the MHC class I\u2013associated immunopeptidome is essential for designing rational combinatorial therapies to enhance antitumor CD8+ T-cell activity, such as immune checkpoint inhibitor Abs. We investigated the impact of a first-in-class inhibitor of cellular NEDDylation, MLN4924, on self-peptide presentation using 2 human tumor cell lines: HeLa cells secreting the human MHC class I protein HLA-A*11:01 and the glioblastoma cell line U87-MG. MLN4924 indirectly inactivates the cullin-RING ligases (CRLs), a large family of E3 ubiquitin ligases responsible for targeting numerous substrates for degradation by the ubiquitin-proteasome system. MLN4924 treatment prevented cell division and altered the transcriptome of HeLa cells in a predictable manner. However, MLN4924 treatment did not alter the cell-surface levels of MHC class I proteins. An analysis of the immunopeptidome and the source proteins, which yielded peptides for presentation, revealed some unexpected findings. Greater than 50% of the peptides presented, and more than two-thirds of the source proteins from which peptides were derived, remained unaltered after MLN4924 treatment. Furthermore, alterations to the transcriptome could not predict the observed changes to the immunopeptidome. Of the approximately 100 CRL substrates that were presented by HLA-A*11:01, most were presented independent of MLN4924 treatment. Alternative degradation pathways and the presence of intron sequences in the specific mRNA transcripts may help explain how these proteins yield peptides for Ag presentation. In summary, MLN4924 treatment only partially affects the immunopeptidomic profile, suggesting it could be used in combinatorial cancer immunotherapies.<\/jats:p>","DOI":"10.1093\/jimmun\/vkag258","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:54:12Z","timestamp":1791665652000},"source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of cellular NEDDylation partially alters the MHC class I immunopeptidome"],"prefix":"10.1093","volume":"215","author":[{"given":"Hooman","family":"Yari","sequence":"first","affiliation":[{"name":"Microbiology & Immunology, The University of Oklahoma Health Sciences Center , Oklahoma City, OK,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Divilov","sequence":"additional","affiliation":[{"name":"Center for Quantitative Life Sciences, Oregon State University , Corvallis, OR,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan T","family":"Fahey","sequence":"additional","affiliation":[{"name":"Carlson College of Veterinary Medicine, Biomedical Sciences, Oregon State University , Corvallis, OR,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4058-0744","authenticated-orcid":false,"given":"Sofia A","family":"Arola","sequence":"additional","affiliation":[{"name":"Carlson College of Veterinary Medicine, Biomedical Sciences, Oregon State University , Corvallis, OR,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H","family":"Hildebrand","sequence":"additional","affiliation":[{"name":"Microbiology & Immunology, The University of Oklahoma Health Sciences Center , Oklahoma City, OK,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5985-1887","authenticated-orcid":false,"given":"Brian P","family":"Dolan","sequence":"additional","affiliation":[{"name":"Carlson College of Veterinary Medicine, Biomedical Sciences, Oregon State University , Corvallis, OR,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"2026102914520883400_vkag258-B1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/eji.201444830","article-title":"Polyubiquitination of lysine-48 is an essential but indirect signal for MHC class I antigen processing","volume":"45","author":"Fiebiger","year":"2015","journal-title":"Eur J Immunol"},{"key":"2026102914520883400_vkag258-B2","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4049\/jimmunol.155.8.3750","article-title":"Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation","volume":"155","author":"Grant","year":"1995","journal-title":"J Immunol"},{"key":"2026102914520883400_vkag258-B3","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.4049\/jimmunol.1003411","article-title":"Cutting edge: selective role of ubiquitin in MHC class I antigen presentation","volume":"186","author":"Huang","year":"2011","journal-title":"J Immunol"},{"key":"2026102914520883400_vkag258-B4","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.4049\/jimmunol.167.3.1212","article-title":"Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors","volume":"167","author":"Luckey","year":"2001","journal-title":"J Immunol"},{"key":"2026102914520883400_vkag258-B5","doi-asserted-by":"publisher","first-page":"eade7890","DOI":"10.1126\/sciadv.ade7890","article-title":"Quantitative measurement of the requirement of diverse protein degradation pathways in MHC class I peptide presentation","volume":"9","author":"Mamrosh","year":"2023","journal-title":"Sci Adv."},{"key":"2026102914520883400_vkag258-B6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/363552a0","article-title":"A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation","volume":"363","author":"Michalek","year":"1993","journal-title":"Nature"},{"key":"2026102914520883400_vkag258-B7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/s0092-8674(94)90462-6","article-title":"Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules","volume":"78","author":"Rock","year":"1994","journal-title":"Cell"},{"key":"2026102914520883400_vkag258-B8","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.4049\/jimmunol.164.12.6147","article-title":"The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses","volume":"164","author":"Schwarz","year":"2000","journal-title":"J Immunol"},{"key":"2026102914520883400_vkag258-B9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1126\/science.1095522","article-title":"An antigenic peptide produced by peptide splicing in the proteasome","volume":"304","author":"Vigneron","year":"2004","journal-title":"Science"},{"key":"2026102914520883400_vkag258-B10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s1074-7613(03)00051-7","article-title":"Quantitating protein synthesis, degradation, and endogenous antigen processing","volume":"18","author":"Princiotta","year":"2003","journal-title":"Immunity"},{"key":"2026102914520883400_vkag258-B11","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.4049\/jimmunol.1602122","article-title":"Varied role of ubiquitylation in generating MHC Class I peptide ligands","volume":"198","author":"Wei","year":"2017","journal-title":"J Immunol"},{"key":"2026102914520883400_vkag258-B12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-981-15-1025-0_3","volume-title":"Cullin-RING ligases and protein neddylation: Biology and therapeutics","author":"Wang","year":"2020"},{"key":"2026102914520883400_vkag258-B13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41586-020-2000-y","article-title":"NEDD8 nucleates a multivalent cullin\u2013RING\u2013UBE2D ubiquitin ligation assembly","volume":"578","author":"Baek","year":"2020","journal-title":"Nature"},{"key":"2026102914520883400_vkag258-B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-981-15-1025-0_2","volume-title":"Cullin-RING ligases and protein neddylation: biology and therapeutics","author":"Rusnac","year":"2020"},{"key":"2026102914520883400_vkag258-B15","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/1947601910382898","article-title":"The NEDD8 conjugation pathway and its relevance in cancer biology and therapy","volume":"1","author":"Soucy","year":"2010","journal-title":"Genes Cancer"},{"key":"2026102914520883400_vkag258-B16","doi-asserted-by":"publisher","first-page":"653882","DOI":"10.3389\/fcell.2021.653882","article-title":"Advances in cancer treatment by targeting the neddylation pathway","volume":"9","author":"Gai","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026102914520883400_vkag258-B17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-981-15-1025-0_18","volume-title":"Cullin-RING ligases and protein neddylation: biology and therapeutics","author":"Zhou","year":"2020"},{"key":"2026102914520883400_vkag258-B18","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"Soucy","year":"2009","journal-title":"Nature"},{"key":"2026102914520883400_vkag258-B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41408-022-00763-w","article-title":"Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed\/refractory B-cell non-Hodgkin lymphoma","volume":"13","author":"Torka","year":"2023","journal-title":"Blood Cancer J"},{"key":"2026102914520883400_vkag258-B20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1182\/blood-2017-09-805895","article-title":"Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML","volume":"131","author":"Swords","year":"2018","journal-title":"Blood"},{"key":"2026102914520883400_vkag258-B21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1158\/1535-7163.MCT-18-0644","article-title":"TAS4464, a highly potent and selective inhibitor of NEDD8-activating enzyme, suppresses neddylation and shows antitumor activity in diverse cancer models","volume":"18","author":"Yoshimura","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"2026102914520883400_vkag258-B22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s10637-020-01055-5","article-title":"A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors","volume":"39","author":"Yamamoto","year":"2021","journal-title":"Invest New Drugs"},{"key":"2026102914520883400_vkag258-B23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2026102914520883400_vkag258-B24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/CCO.0000000000000925","article-title":"Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers","volume":"35","author":"Tas","year":"2023","journal-title":"Curr Opin Oncol"},{"key":"2026102914520883400_vkag258-B25","doi-asserted-by":"publisher","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front Immunol"},{"key":"2026102914520883400_vkag258-B26","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.cell.2017.09.050","article-title":"MHC-I genotype restricts the oncogenic mutational landscape","volume":"171","author":"Marty","year":"2017","journal-title":"Cell"},{"key":"2026102914520883400_vkag258-B27","doi-asserted-by":"publisher","first-page":"eabg8070","DOI":"10.1126\/scitranslmed.abg8070","article-title":"Targeting an alternate Wilms\u2019 tumor antigen 1 peptide bypasses immunoproteasome dependency","volume":"14","author":"Lahman","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026102914520883400_vkag258-B28","doi-asserted-by":"publisher","first-page":"e66298","DOI":"10.1371\/journal.pone.0066298","article-title":"Identification of class I HLA T cell control epitopes for West Nile virus","volume":"8","author":"Kaabinejadian","year":"2013","journal-title":"PLoS One."},{"key":"2026102914520883400_vkag258-B29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The NF-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2026102914520883400_vkag258-B30","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2026102914520883400_vkag258-B31","doi-asserted-by":"publisher","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler\u2014interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"2026102914520883400_vkag258-B32","unstructured":"Dainat J. \u00a0AGAT: Another Gff Analysis Toolkit to handle annotations in any GTF\/GFF format. (Version v1.4.1). Zenodo. 10.5281\/zenodo.3552717"},{"key":"2026102914520883400_vkag258-B33","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41596-019-0133-y","article-title":"Mass spectrometry\u2013based identification of MHC-bound peptides for immunopeptidomics","volume":"14","author":"Purcell","year":"2019","journal-title":"Nat Protoc"},{"key":"2026102914520883400_vkag258-B34","doi-asserted-by":"publisher","first-page":"115975","DOI":"10.1016\/j.isci.2026.115975","article-title":"Presentation of identical tumor antigen peptides by canine and human MHC class I","volume":"29","author":"Kaabinejadian","year":"2026","journal-title":"iScience"},{"key":"2026102914520883400_vkag258-B35","doi-asserted-by":"publisher","first-page":"835454","DOI":"10.3389\/fimmu.2022.835454","article-title":"Accurate MHC motif deconvolution of immunopeptidomics data reveals a significant contribution of DRB3, 4 and 5 to the total DR immunopeptidome","volume":"13","author":"Kaabinejadian","year":"2022","journal-title":"Front Immunol"},{"key":"2026102914520883400_vkag258-B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/bioinformatics\/bts621","article-title":"Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach","volume":"29","author":"Andreatta","year":"2013","journal-title":"Bioinformatics"},{"key":"2026102914520883400_vkag258-B37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12964-020-00576-z","article-title":"Neddylation inhibition activates the protective autophagy through NF-\u03baB-catalase-ATF3 axis in human esophageal cancer cells","volume":"18","author":"Liang","year":"2020","journal-title":"Cell Commun Signal"},{"key":"2026102914520883400_vkag258-B38","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1158\/0008-5472.CAN-12-0388","article-title":"The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth","volume":"72","author":"Luo","year":"2012","journal-title":"Cancer Res"},{"key":"2026102914520883400_vkag258-B39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2011.09.019","article-title":"Global identification of modular cullin-RING ligase substrates","volume":"147","author":"Emanuele Michael","year":"2011","journal-title":"Cell"},{"key":"2026102914520883400_vkag258-B40","doi-asserted-by":"publisher","first-page":"M111.009183","DOI":"10.1074\/mcp.M111.009183","article-title":"Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8-activating enzyme by MLN4924","volume":"10","author":"Liao","year":"2011","journal-title":"Mol Cell Proteomics."},{"key":"2026102914520883400_vkag258-B41","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.mcpro.2023.100644","article-title":"Pulse-SILAC and interactomics reveal distinct DDB1-CUL4-associated factors, cellular functions, and protein substrates","volume":"22","author":"Raisch","year":"2023","journal-title":"Mol Cell Proteomics"},{"key":"2026102914520883400_vkag258-B42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2020.04.003","article-title":"Cullin-RING ligase 5: functional characterization and its role in human cancers","volume":"67","author":"Zhao","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"2026102914520883400_vkag258-B43","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1101\/gad.1624008","article-title":"WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase","volume":"22","author":"Hu","year":"2008","journal-title":"Genes Dev"},{"key":"2026102914520883400_vkag258-B44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13008-016-0020-7","article-title":"The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions","volume":"11","author":"Cai","year":"2016","journal-title":"Cell Div"},{"key":"2026102914520883400_vkag258-B45","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.7150\/ijbs.40235","article-title":"Small molecule NSC1892 targets the CUL4A\/4B-DDB1 interactions and causes impairment of CRL4DCAF4 E3 ligases to inhibit colorectal cancer cell growth","volume":"16","author":"Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"2026102914520883400_vkag258-B46","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI129107","article-title":"Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development","volume":"129","author":"Wang","year":"2019","journal-title":"J Clin Invest"},{"key":"2026102914520883400_vkag258-B47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"2026102914520883400_vkag258-B48","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1593\/neo.06520","article-title":"Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex","volume":"8","author":"Sufan","year":"2006","journal-title":"Neoplasia"},{"key":"2026102914520883400_vkag258-B49","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1073\/pnas.0307700101","article-title":"M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCF\u03b2-TrCP","volume":"101","author":"Watanabe","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026102914520883400_vkag258-B50","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1073\/pnas.92.17.7976","article-title":"A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma","volume":"92","author":"Coulie","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026102914520883400_vkag258-B51","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1084\/jem.183.3.1173","article-title":"A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene","volume":"183","author":"Guilloux","year":"1996","journal-title":"J Exp Med"},{"key":"2026102914520883400_vkag258-B52","doi-asserted-by":"publisher","first-page":"17951","DOI":"10.1073\/pnas.1309956110","article-title":"Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway","volume":"110","author":"Apcher","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026102914520883400_vkag258-B53","doi-asserted-by":"publisher","first-page":"e2208509120","DOI":"10.1073\/pnas.2208509120","article-title":"Major histocompatibility class I antigenic peptides derived from translation of pre-mRNAs generate immune tolerance","volume":"120","author":"Sroka","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026102914520883400_vkag258-B54","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nbt.4239","article-title":"Intron retention is a source of neoepitopes in cancer","volume":"36","author":"Smart","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2026102914520883400_vkag258-B55","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.3389\/fimmu.2018.03098","article-title":"Endocytic recycling of MHC class I molecules in non-professional antigen presenting and dendritic cells","volume":"9","author":"Montealegre","year":"2018","journal-title":"Front Immunol"},{"key":"2026102914520883400_vkag258-B56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2019.12.003","article-title":"Endogenous TAP-independent MHC-I antigen presentation: not just the ER lumen","volume":"64","author":"Del Val","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"2026102914520883400_vkag258-B57","doi-asserted-by":"publisher","first-page":"102356","DOI":"10.1016\/j.coi.2023.102356","article-title":"Major histocompatibility complex class I assembly within endolysosomal pathways","volume":"84","author":"Olson","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"2026102914520883400_vkag258-B58","doi-asserted-by":"publisher","first-page":"e79144","DOI":"10.7554\/eLife.79144","article-title":"Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes","volume":"12","author":"Olson","year":"2023","journal-title":"Elife"},{"key":"2026102914520883400_vkag258-B59","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.2025029727","article-title":"The conundrum of drug development in higher-risk MDS: lessons learned from recently failed phase 3 clinical trials","volume":"147","author":"Stahl","year":"2026","journal-title":"Blood"},{"key":"2026102914520883400_vkag258-B60","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1172\/JCI88590","article-title":"MHC class I-associated peptides derive from selective regions of the human genome","volume":"126","author":"Pearson","year":"2016","journal-title":"J Clin Invest"},{"key":"2026102914520883400_vkag258-B61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1074\/mcp.M600310-MCP200","article-title":"Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface","volume":"6","author":"Weinzierl","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"2026102914520883400_vkag258-B62","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1084\/jem.20071985","article-title":"The MHC class I peptide repertoire is molded by the transcriptome","volume":"205","author":"Fortier","year":"2008","journal-title":"J Exp Med"},{"key":"2026102914520883400_vkag258-B63","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41467-020-14968-9","article-title":"Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes","volume":"11","author":"Chong","year":"2020","journal-title":"Nat Commun"},{"key":"2026102914520883400_vkag258-B64","doi-asserted-by":"publisher","first-page":"103768","DOI":"10.1016\/j.isci.2022.103768","article-title":"Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues","volume":"25","author":"Kubiniok","year":"2022","journal-title":"iScience"},{"key":"2026102914520883400_vkag258-B65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","article-title":"Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction","volume":"46","author":"Abelin","year":"2017","journal-title":"Immunity"},{"key":"2026102914520883400_vkag258-B66","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1182\/blood-2012-02-412593","article-title":"MHC I\u2013associated peptides preferentially derive from transcripts bearing miRNA response elements","volume":"119","author":"Granados","year":"2012","journal-title":"Blood."},{"key":"2026102914520883400_vkag258-B67","doi-asserted-by":"publisher","first-page":"e1002517","DOI":"10.1371\/journal.pcbi.1002517","article-title":"Proteome sampling by the HLA class I antigen processing pathway","volume":"8","author":"Hoof","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"2026102914520883400_vkag258-B68","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1074\/mcp.M116.060350","article-title":"Human leukocyte antigen (HLA) peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy","volume":"15","author":"Shraibman","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"2026102914520883400_vkag258-B69","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1016\/j.cell.2021.05.038","article-title":"Pharmacologic modulation of RNA splicing enhances anti-tumor immunity","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/10\/vkag258\/71838727\/vkag258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/10\/vkag258\/71838727\/vkag258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:52:14Z","timestamp":1793299934000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/doi\/10.1093\/jimmun\/vkag258\/8907379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jimmun\/vkag258","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,10,1]]},"article-number":"vkag258"}}